- Home
- ARBE vs CDXS Comparison
ARBE vs CDXS Comparison
Compare ARBE & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBE | CDXS |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.0M | 141.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | ARBE | CDXS |
|---|---|---|
| Price | $1.86 | $1.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.63 | N/A |
| AVG Volume (30 Days) | ★ 6.2M | 805.0K |
| Earning Date | 03-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $667,000.00 | ★ $52,932,000.00 |
| Revenue This Year | $69.79 | $15.64 |
| Revenue Next Year | $576.46 | $5.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.85 | $1.52 |
| 52 Week High | $3.37 | $5.43 |
Technical Indicators
Market Signals| Indicator | ARBE | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 70.71 | 58.06 |
| Support Level | $1.16 | $1.61 |
| Resistance Level | $1.34 | $1.74 |
| Average True Range (ATR) | 0.16 | 0.08 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 86.06 | 92.59 |
Price Performance
Historical ComparisonAbout ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.